TotalMarketCap

Evolus

EOLSNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$452.397 M

$6.84 -8.50%

Close of 6 Nov 2026

As of 6 Nov 2026, Evolus (EOLS) has a market capitalization of $452.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$297.2M

#2121 by revenue

Earnings

-$51.6M

Loss-making

Shares outstanding

66,188,366

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #193CytomX TherapeuticsCTMX$467.4M
  2. #194Aquestive TherapeuticsAQST$458.1M
  3. #195EvolusEOLS$452.4M
  4. #196Monopar TherapeuticsMNPR$450.8M
  5. #197Shattuck LabsSTTK$450.1M

What if Evolus were worth as much as…

Open the what-if tool →

Gold $28.2T

$426,613.85

Per share 62,416× higher

Bitcoin $1.53T

$23,083.33

Per share 3,377× higher

Apple $5.02T

$75,780.43

Per share 11,087× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Evolus are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.